Risk Factors for Staphylococcus Aureus Surgical Site Infections in Orthopedic and Trauma Surgery (ISO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03040960|
Recruitment Status : Unknown
Verified October 2017 by University Hospital, Grenoble.
Recruitment status was: Recruiting
First Posted : February 2, 2017
Last Update Posted : October 11, 2017
|Condition or disease|
|Staphylococcus Aureus Surgical Wound Infection Orthopedic Disorder Traumatology|
Surgical site infections (SSI) in orthopedic surgery are responsible for reduced quality of life, increased length of hospital stay and costs. The most commonly identified organism is Staphylococcus aureus but risk factors for mono microbial S.aureus SSI are not well-known.The aim of this study was to evaluate the incidence rate trend of S. aureus SSI over the years and risk factors of theses infections in a french University Hospital.
The knowledge obtained by this study will enable identification of the surgical patients most at risk of developping S. aureus SSI, and who would probably benefit most from new interventions given prophylactically and specifically to prevent S. aureus infections.
|Study Type :||Observational|
|Estimated Enrollment :||150 participants|
|Official Title:||Risk Factors for Staphylococcus Aureus Surgical Site Infections in Orthopedic and Trauma Surgery|
|Study Start Date :||August 2016|
|Estimated Primary Completion Date :||August 2018|
|Estimated Study Completion Date :||August 2018|
- Risk factors of S. aureus surgical site infections. [ Time Frame: up to 1 year following surgery ]univariate analysis of potential risk factors. Data with p value less than 0.1 were included in a logistic regression model
- The incidence rate trend of S. aureus SSI over the year. [ Time Frame: from january 1st 2012 to april 30th 2015 ]linear regression slope test of S. aureus SSI incidence rates by years
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03040960
|Contact: Caroline Landelle, PHemail@example.com|
|University Hospital, Grenoble Alpes||Recruiting|
|Grenoble, France, 38043|
|Contact: Caroline Landelle 0033476765643 firstname.lastname@example.org|
|Principal Investigator:||Caroline landelle, PH||University Hospital, Grenoble|